Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Ponatinib in Biliary Cancer Patients With FGFR2 Fusions

NCT02265341 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02265341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02265341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Ponatinib in Biliary Cancer Patients With FGFR2 Fusions
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2014
Completion date
June 14, 2019
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant hepatobiliary neoplasm